Immunome Inc.
IMNM
16 insider filings · Latest: Jun 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jun 30 9:20 PM | ABHMC II, LLC | Proposed Sale | 100,000 | $21.04 | $2.1M | — | View → |
| Jun 30, 2026 | Jun 30 9:20 PM | Arsenal Bridge Venture II-B, LLC | Proposed Sale | 1,050 | $21.04 | $22.1K | — | View → |
| Jun 25, 2026 | Jun 29 8:52 PM | Robert LechleiderChief Medical Officer | Sale | 55,000 | $19.85 | $1.1M | 15,805(D) | View → |
| Jun 25, 2026 | Jun 25 1:47 PM | Lechleider Robert | Proposed Sale | 55,000 | $19.73 | $1.1M | — | View → |
| Jun 15, 2026 | Jun 17 9:26 PM | Max RosettChief Financial Officer | Sale | 60,000 | $18.23 | $1.1M | 54,037(D) | View → |
| Jun 15, 2026 | Jun 15 6:36 PM | Rosett Max | Proposed Sale | 60,000 | $18.63 | $1.1M | — | View → |
| Jun 5, 2026 | Jun 9 9:40 PM | Jean Jacques BienaimeDirector | Purchase | 10,500 | $19.45 | $204.3K | 43,415(D) | View → |
| Jun 5, 2026 | Jun 9 9:40 PM | Jean Jacques BienaimeDirector | Sale | 10,500 | $19.41 | $203.8K | 32,915(D) | View → |
| May 15, 2026 | May 19 11:56 AM | Jean Jacques BienaimeDirector | Purchase | 5,000 | $20.70 | $103.5K | 43,415(D) | View → |
| Apr 2, 2026 | Apr 3 11:48 PM | Jack HigginsChief Scientific Officer | Sale | 9,438 | $21.64 | $204.2K | 22,000(D) | View → |
| Apr 2, 2026 | Apr 3 11:46 PM | Max RosettChief Financial Officer | Sale | 65,000 | $21.92 | $1.4M | 54,037(D) | View → |
| Apr 2, 2026 | Apr 3 1:49 PM | Rosett Max | Proposed Sale | 65,000 | $21.92 | $1.4M | — | View → |
| Apr 2, 2026 | Apr 2 3:46 PM | Rosett Max | Proposed Sale | 65,000 | $72.67 | $4.7M | — | View → |
| Apr 2, 2026 | Apr 2 3:32 PM | Higgins Jack | Proposed Sale | 9,438 | $21.64 | $204.2K | — | View → |
| Mar 27, 2026 | Mar 31 11:11 AM | Clay B SiegallDirector, President and CEO | Purchase | 25,450 | $19.67 | $500.6K | 690,704(D) | View → |
| Mar 23, 2026 | Mar 24 1:23 AM | WAGENHEIM PHILIPDirector | Sale | 28,200 | $20.65 | $582.3K | 341,147(D) | View → |
| Mar 20, 2026 | Mar 24 1:23 AM | WAGENHEIM PHILIPDirector | Sale | 36,800 | $20.47 | $753.3K | 369,347(D) | View → |
| Mar 20, 2026 | Mar 20 4:56 PM | WAGENHEIM PHILIP | Proposed Sale | 65,000 | $20.81 | $1.4M | — | View → |
| Mar 11, 2026 | Mar 12 10:05 AM | Jean Jacques BienaimeDirector | Purchase | 1,000 | $21.55 | $21.6K | 38,415(D) | View → |
| Mar 10, 2026 | Mar 12 10:05 AM | Jean Jacques BienaimeDirector | Purchase | 1,000 | $22.12 | $22.1K | 37,415(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Jun 29 8:52 PM | Robert LechleiderChief Medical Officer | Option Exercise | 55,000 | $8.73 | 345,000(D) | View → |
| Jun 15, 2026 | Jun 17 9:26 PM | Max RosettChief Financial Officer | Option Exercise | 60,000 | $1.05 | 0(D) | View → |
| Jun 10, 2026 | Jun 12 9:58 PM | Sandra M SwainDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Jun 10, 2026 | Jun 12 9:56 PM | WAGENHEIM PHILIPDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Jun 10, 2026 | Jun 12 9:54 PM | Jean Jacques BienaimeDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Jun 10, 2026 | Jun 12 9:51 PM | James P BoylanDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Jun 10, 2026 | Jun 12 9:48 PM | Barchas IsaacDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Jun 10, 2026 | Jun 12 9:45 PM | Carol SchaferDirector | Grant/Award | 9,897 | $18.16 | 9,897(D) | View → |
| Apr 2, 2026 | Apr 3 11:46 PM | Max RosettChief Financial Officer | Option Exercise | 71,561 | $1.35 | 0(D) | View → |